Is Health Screening in China Safe? An Honest Guide

April 9, 2026

Medically reviewed by Jane Xi, MD, CMDA

This content is for informational purposes only and does not constitute medical advice.

China has 1,876 Grade 3A hospitals. Forty-six held JCI accreditation as of December 2022. And then, in 2023, JCI stopped operating in China.

Most of the content you'll find about health screening safety in China doesn't mention this. That omission tells you something about how this topic is usually written — by people who haven't looked closely at the accreditation landscape, or who have a reason to keep the picture simple.

This guide doesn't do that. It will tell you what Grade 3A certification actually means, what happened to JCI in China and why it matters, what the real documented risks are (they're not what most people assume), and the five questions worth asking before you book anything.

Key Takeaways

China ranks 32nd globally in healthcare quality; top-tier facilities report surgical site infection rates of 0.5–1.5%, comparable to leading US hospitals (MedBridgeNZ, 2025)

JCI stopped operating in China in 2023 — most health tourism content hasn't caught up with this change

The primary documented risks for foreign visitors are overdiagnosis from over-imaging and language-driven misinterpretation of results — not clinical error

Ask five specific questions before booking any health checkup in China (listed in this guide)

What "Safe" Actually Means for a Health Checkup in China

China ranks 32nd globally in healthcare quality with a score of 68.7 (WHO Global Health Index, 2025). Top-tier Chinese hospitals report surgical site infection rates of 0.5–1.5%, comparable to the US average of 1–2%. Over 500,000 international patients used Chinese healthcare facilities in 2025 (Future Market Insights, 2025). At accredited facilities, the clinical picture is broadly solid.

The honest reframe is this: the question "is health screening in China safe?" is usually conflating two separate things. One is clinical quality — equipment, technique, staff training, infection control. The other is the navigational experience — understanding the process, communicating your needs, receiving and interpreting results. These are not the same problem, and they don't carry the same risk profile.

At a Grade 3A or otherwise accredited facility, clinical quality is not the primary concern for most health screenings. The technology is comparable to what you'd find at a Western facility. The diagnostic capability is there. What's different is everything around the clinical encounter: queue systems that don't follow logic a Western visitor recognises, staff whose English ranges from functional to absent, reports issued in Chinese with no accompanying explanation.

That navigational gap is where most problems for foreign visitors originate. A misunderstood test result is not a clinical failure — but it can have the same practical consequences as one. A package that includes imaging you don't need isn't dangerous in itself, but it produces findings that require context to interpret correctly.

When clients contact Goji after booking independently, the most common issue isn't that anything went clinically wrong. It's that they received a report in Chinese, identified one flagged finding, and had no way to know whether it required immediate follow-up or was a routine notation. That gap — between the test result and what it means for you — is the safety question that matters most.

Clean modern hospital corridor — health checkup in China for foreigners

Grade 3A: What China's Top Hospital Certification Actually Covers

China has a three-tier hospital classification system administered by the National Health Commission. Grade 3A (三甲, sān jiǎ) is the highest designation — and only 1,876 hospitals nationally hold it out of approximately 36,000 registered facilities (China National Health Commission, 2025). That's roughly 5% of all hospitals. It is a meaningful bar.

To achieve and maintain Grade 3A status, a hospital must demonstrate advanced technical capability across multiple specialisms, pass regular government-administered inspections, maintain documented quality improvement processes, and meet standards for infection control, medication safety, and clinical outcomes. These are not self-reported criteria. They're verified by inspection teams with the authority to revoke status.

Source: China National Health Commission, 2025. Figures are approximate. Grade 3A represents the top designation within the Grade 3 tier.

What Grade 3A doesn't cover is equally important to understand. The certification assesses clinical capability, not patient experience. It doesn't measure English-language service provision. It doesn't assess whether international patients can navigate the appointment process independently. It doesn't evaluate the clarity or format of written reports.

A Grade 3A hospital is the right baseline quality floor for a health checkup in China. It is not, by itself, a guarantee that the experience will be navigable for a foreign visitor without additional support.

Goji uses Grade 3A certification as the entry criterion when evaluating partner facilities — but not as the exit criterion. A facility can hold Grade 3A status and still not make the shortlist because of how it handles international patient communication, report turnaround, or package transparency. The badge is the floor, not the ceiling.

JCI Accreditation in China: What Changed in 2023

As of December 2022, 46 Chinese healthcare organisations held JCI accreditation — making China the 5th-largest country for JCI-certified facilities globally, representing 5% of the total 946 institutions worldwide (Joint Commission International, 2022). JCI accreditation meant a facility had been inspected against the same standards the Joint Commission uses to evaluate US hospitals — patient safety systems, infection control protocols, medication management, staff qualifications, and continuous improvement processes.

In 2023, JCI stopped operating in China. This is a significant change that almost no English-language health tourism content acknowledges. If you search for "JCI accredited hospitals China" today, you'll still find sites listing JCI as the primary quality signal — including some that list specific facilities as "JCI-accredited" without noting that those accreditations may have lapsed. This isn't necessarily dishonest; most of this content was written before the change or hasn't been updated. But it means the accreditation landscape looks different from what most content describes.

What replaced JCI is China's own International Hospital Accreditation Standards, first introduced through a Shenzhen pilot in 2022 and certified by ISQua (the International Society for Quality in Healthcare) — the same body that accredits JCI itself. Some facilities have pursued this domestic accreditation pathway. Others have maintained accreditation through alternative international bodies. A small number of facilities that held JCI accreditation before the exit may still reference it; the status of those historic accreditations depends on the individual facility and the terms of the original certification.

The practical implication for anyone researching health checkups in China: don't take "JCI-accredited" as a reliable current signal without confirming the specific facility's current status directly. Grade 3A, combined with direct assessment of the facility's international patient capability, is a more reliable indicator right now.

The Real Risks of Health Screening in China

The documented risks for foreign visitors at accredited Chinese health screening facilities are not what most people anticipate. Equipment quality is not the concern. Clinical staff training is not the concern. The specific risks that appear in peer-reviewed research are more granular than that.

Overdiagnosis and over-imaging. Low-dose CT (LDCT) scans have been widely included in health checkup packages in China regardless of individual clinical indication — offered to staff annually without reference to age, smoking status, or risk factors. Long-term trial data shows an LDCT overdiagnosis rate ranging from 0 to 67% (ScienceDirect, 2024; Nature Scientific Reports, 2024). The practical implication: a finding on your health checkup report in China is not automatically cause for concern. Context matters — especially whether the test was clinically indicated for your profile in the first place.

False positives. The surgical false-positive biopsy rate in LDCT screening studies in China is 4.17% overall — rising to 7.69% in populations where screening was not clinically indicated (Nature Scientific Reports, 2024). This is a research finding, not a clinical failure — but it means that additional procedures following a screening finding don't always confirm what the original scan suggested.

Language-driven result misinterpretation. A Chinese-language report with no translation is a practical safety risk. Not because the test was performed incorrectly, but because a finding that isn't read and understood is effectively a missed finding. This is the most avoidable of the risks — and it's entirely a function of whether you have English-language support for your results.

Facility selection. Grade 3A certification covers clinical capability. It does not cover patient experience, English service provision, or report quality. An appropriate facility for a foreign visitor requires more than national accreditation — it requires an established international patient department, documented English-language capability, and a clear process for result delivery and follow-up.

Medical report documents and test results — understanding health checkup findings in China

How Goji Vets Partner Facilities

Goji works with a small number of partner facilities — not a directory of every Grade 3A hospital in China. The distinction matters because the vetting process eliminates facilities that hold national certification but don't meet the additional criteria that matter for a foreign visitor.

The baseline requirement for any Goji partner facility is Grade 3A certification under the China National Health Commission. That's the floor, not the selection criterion. On top of that, every facility Goji works with must have an established international patients department with English-capable clinical and administrative staff, demonstrate an established process for handling foreign visitor appointments from pre-booking through to result delivery, and provide bilingual report delivery within a confirmed turnaround window.

During the initial facility assessment process, one factor that consistently separated shortlisted facilities from rejected ones wasn't clinical quality — it was what happened after the appointment. Specifically: whether the facility had a clear process for a foreign visitor to ask a follow-up question about their results in English, and who they would contact. Some facilities with excellent clinical reputations couldn't answer that question with any specificity. Those facilities didn't make the shortlist, regardless of their accreditation status.

Goji is a coordination intermediary, not a clinical provider. The partner facilities deliver the clinical services. Goji's role is to ensure the right facility is matched to the right client, that the appointment is confirmed and prepared in advance, that a coordinator is available throughout the process, and that the report is delivered in a format the client can actually use.

Five Questions to Ask Before Booking Any Health Checkup in China

Independent travelers now comprise approximately 55% of medical tourists to China (Future Market Insights, 2025). Most book without asking the questions that would most reduce their risk. If you're booking a health checkup in China — whether through Goji or independently — these five questions are worth getting answers to before you confirm anything.

Person reviewing documents before booking a health checkup — questions to ask

1. Is the facility Grade 3A certified? This is the quality floor. It doesn't guarantee a good experience, but it rules out a large number of facilities that haven't met China's national clinical standards. Don't book at anything below this tier.

2. Does the facility have an international patients department with English-speaking clinical staff? Not a reception desk that speaks basic English. An established department with documented capability to handle foreign visitors from booking through to result delivery. Ask specifically — don't assume this exists because the website has an English version.

3. Will the report be available in English or bilingual, and within what timeframe? Get a specific answer to this before you book. "We can arrange translation" is not the same as "we deliver a bilingual certified report within 48 hours." Know what you're actually getting.

4. What happens if a test result needs follow-up — and who do you contact? This is the question most people don't think to ask until they need the answer. If a finding on your report requires clarification or a specialist referral, is there a point of contact who can explain it to you in English? If the answer is vague, that's information.

5. Are the tests in the package clinically indicated for your age and risk profile? Not every test in a health checkup package is appropriate for every person. LDCT lung screening, for example, is recommended for adults over 50 with a significant smoking history — it's a different risk-benefit calculation for a healthy 35-year-old non-smoker. If a package includes imaging tests without reference to your profile, ask why those tests are included for you specifically.

China vs Other Asian Health Screening Destinations

China, South Korea, and Thailand are the three primary Asian destinations for international health screening. Each has a different cost and quality-experience profile. The brief comparison below is enough for orientation; a fuller breakdown is coming in a separate guide.

	China	South Korea	Thailand
Cost vs US	70–85% lower	60–75% lower	50–70% lower
Accreditation	Grade 3A / ISQua-certified domestic standards	KOIHA / JCI (active)	JCI (active)
English service	Variable — strongest in intl. departments	Strong at major private facilities	Strong at international hospitals
Coordination need	High for most foreign visitors	Moderate	Low–moderate

The JCI exit from China in 2023 is China-specific. JCI remains active in South Korea and Thailand, where JCI-accredited facilities are the relevant quality signal. For visitors whose primary concern is accreditation legibility — a single standard they can verify independently — South Korea and Thailand have a simpler landscape in that respect. China's Grade 3A system is equally rigorous, but less immediately recognisable to someone unfamiliar with it.

China's cost advantage is real and significant. The coordination requirement is also real and significant. Those two facts tend to travel together.

Frequently Asked Questions

Is a Grade 3A hospital in China safe for a foreigner?

A Grade 3A hospital meets China's highest national standards for clinical capability — assessed by regular government inspection across technical performance, infection control, and patient safety systems. For a foreign visitor, clinical safety at a Grade 3A facility is comparable to leading Western hospitals. The primary challenge is navigational, not clinical: language, process legibility, and result interpretation require additional support that Grade 3A status alone doesn't provide.

Does JCI accreditation still apply to hospitals in China?

JCI stopped operating in China in 2023. Existing JCI accreditations from before that date may have lapsed. China has introduced its own ISQua-certified International Hospital Accreditation Standards as a domestic alternative. When evaluating a facility, ask specifically about its current accreditation status rather than relying on historic JCI listings — most published content on this topic hasn't been updated to reflect the change.

What is the biggest risk with health screening in China?

For most foreign visitors at accredited facilities, the largest documented risks are overdiagnosis from over-imaging — particularly lung CT scans offered to patients outside recommended screening criteria, with overdiagnosis rates ranging 0–67% in peer-reviewed trial data (Nature / ScienceDirect, 2024) — and language-driven misinterpretation of results. Clinical error at vetted, Grade 3A facilities is not the primary concern. Navigational failure is.

How does Goji select which facilities to work with?

Goji works with a small number of partner facilities that meet Grade 3A certification as a baseline, have established international patient departments with English-capable clinical staff, and provide bilingual report delivery within a confirmed timeframe. Goji does not list all accredited facilities in China — it works only with facilities assessed directly against these criteria. Some partner facilities hold JCI or ISQua-certified accreditation in addition to Grade 3A; Goji does not claim this applies to all partners.

Can I book a health checkup in China without a coordinator?

Yes. Many foreign visitors book directly, particularly at private international hospitals in major cities. The tradeoff is managing appointment logistics, language, package selection, and result interpretation independently. A coordinator is most valuable when the process is unfamiliar, the report language is a barrier, or when a finding needs follow-up explanation. If you're comfortable navigating all three of those independently, direct booking is a viable option.

What This Means Before You Book

The headline answer to "is health screening in China safe?" is yes — at accredited facilities, for most people, for most types of health checkup. That answer comes with three practical qualifications.

Clinical safety at Grade 3A and vetted partner facilities is comparable to leading Western hospitals. The equipment, the technique, and the clinical staff training meet rigorous national standards.
JCI accreditation in China changed in 2023. Verify current accreditation status before treating any historic listing as a live signal.
The real risks are navigational: over-imaging relative to your risk profile, language barriers around result interpretation, and gaps in follow-up support. These are avoidable with the right preparation and support.

Asking the five questions in this guide before you book eliminates most of the avoidable risk. What remains is the ordinary uncertainty that comes with any health screening — not a China-specific problem.

If you'd rather skip the research and book with a facility Goji has already assessed, see our packages or speak to a coordinator directly to confirm which option fits your profile and city.

Harvey Sun grew up in a family of doctors and spent years navigating China's healthcare system firsthand before founding Goji Health Care. A Duke University graduate, he was among the first to identify the coordination gap — not clinical quality — as the primary barrier for foreign visitors seeking health checkups in China.

Sources: